Merck & Co., Inc. (NYSE:MRK) is a trending stock this week, with Joseph Terranova of Virtus Investment Partners recently buying shares. Impax US Sustainable Economy Fund noted MRK’s high Corporate Resilience score and contributions to the healthcare system, despite concerns about its drug pipeline and market sentiment. While MRK holds potential, some believe AI stocks offer greater promise for returns. Explore more stocks that could double in 3 years or hidden AI stocks to buy now.

Read more at Yahoo Finance: Analyst Says He’s Buying Merck (MRK) as ‘Market Turns Towards Quality’